spacer
home > ebr > spring 2017 > managing e&l unknown compounds
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

Industry Events

7th annual Orphan Drugs and Rare Diseases UK

18-19 October 2017, Holiday Inn Kensington Forum, London

SMi Group is thrilled to present the 7th annual Orphan Drugs and Rare Diseases conference, taking place on 18th & 19th October 2017 in Central London, UK. This yearís theme will be focused towards discussing strategies for patient engagement, market access and gene therapies to enhance rare diseases and orphan drug research.
More info >>

 
News and Press Releases

YHEC announced appointment of Stuart Mealing as Associate Director of Health Technology Assessment

YHEC is pleased to announce the appointment of Stuart Mealing as Associate Director of Health Technology Assessment. Stuart will be leading the YHEC economic evaluation and modelling team. Stuart has a Masterís degree in operational research from the University of Lancaster Business School and a post-graduate certificate in international business management from Smurfit Business School, Dublin.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement